Abstract
We complement the discussion by Brindisi et al. [1] on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID‐19) pandemic. Brindisi et al. [1] presented a well‐reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID‐19 pandemic where they recommend continuation of the former while withholding of the latter upon risk‐benefit assessment.
| Original language | English |
|---|---|
| Pages (from-to) | 2151 |
| Number of pages | 1 |
| Journal | Acta Paediatrica, International Journal of Paediatrics |
| Volume | 109 |
| Issue number | 10 |
| Early online date | 19 Jul 2020 |
| DOIs | |
| Publication status | Published - 1 Oct 2020 |
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Montelukast in children with allergic rhinitis amid COVID‐19 pandemic'. Together they form a unique fingerprint.Press/Media
-
Study says inhalers OK to use amid COVID-19 concerns
Hamid Merchant, Syed Shahzad Hasan, Toby Capstick, Syed Tabish Razi Zaidi & Chia Siang Kow
7/07/20 → 13/07/20
13 items of Media coverage
Press/Media: Research